This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Masayuki Nadai: Innovator in Therapeutic Drug Development
Introduction
Masayuki Nadai is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of medicine, particularly in the development of therapeutic drugs. His innovative work focuses on addressing critical health issues related to endotoxin blood symptoms and multi-organ failure.
Latest Patents
Masayuki Nadai holds a patent for a therapeutic drug designed to combat endotoxin blood symptoms and the multi-organ failure induced by it. This therapeutic drug comprises sialic acid, its salts, and polymers of sialic acid as effective components. The drug demonstrates high therapeutic effects for shock death and organ failure caused by endotoxin, ensuring both efficacy and safety. It is particularly effective in treating endotoxin-shock and organ failure.
Career Highlights
Throughout his career, Nadai has focused on innovative solutions in the medical field. His dedication to research and development has led to advancements that can significantly improve patient outcomes. His work is characterized by a commitment to safety and effectiveness in therapeutic applications.
Collaborations
Masayuki Nadai has collaborated with notable colleagues, including Michio Ohta and Takaaki Hasegawa. These partnerships have fostered a collaborative environment that enhances the development of innovative therapeutic solutions.
Conclusion
Masayuki Nadai's contributions to the field of therapeutic drug development highlight his role as a key innovator. His work in creating effective treatments for serious medical conditions showcases the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile